Ang-2 inhibitors belong to a specific chemical class of compounds that target and inhibit the action of Angiopoietin-2 (Ang-2). Ang-2 is a naturally occurring protein that plays a critical role in regulating blood vessel formation and maturation, a process known as angiogenesis. It functions as a key modulator of vascular remodeling during various physiological and pathological conditions. Ang-2, along with other factors, mediates the dynamic balance between vessel stabilization and vessel destabilization. By binding to specific receptors on endothelial cells, Ang-2 promotes vessel destabilization and leakage, contributing to the formation of new blood vessels.
Ang-2 inhibitors work by interfering with the interaction between Ang-2 and its receptors on endothelial cells. By doing so, they modulate the angiogenesis process and impact the formation and maturation of blood vessels. These inhibitors have garnered significant attention in the scientific community due to their role in influencing angiogenesis-related processes in diverse contexts, such as wound healing, tissue regeneration, and various diseases like cancer and inflammatory disorders. Research into Ang-2 inhibitors is ongoing to elucidate their mechanisms of action and further understand their implications in different physiological and pathological conditions. The study of Ang-2 inhibitors represents a captivating area of research with promising avenues for future investigations in the field of biomedical science.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
A tyrosine kinase inhibitor that blocks Ang-2-induced phosphorylation and activation of Tie2 receptor, thereby reducing angiogenesis. | ||||||
TG101348 | 936091-26-8 | sc-364740 sc-364740A | 5 mg 25 mg | $207.00 $515.00 | 6 | |
Selective inhibitor of Ang-2/Tie2 interaction, preventing angiogenic signaling and blood vessel destabilization. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Multitargeted kinase inhibitor that blocks receptors involved in angiogenesis, including Ang-2, suppressing tumor blood supply. | ||||||
Cevimeline | 107233-08-9 | sc-353133 | 25 mg | $1800.00 | ||
Inhibits Ang-2 expression by modulating M3 muscarinic receptor, reducing angiogenic responses. | ||||||
ABT-869 | 796967-16-3 | sc-359037 sc-359037A | 1 mg 5 mg | $126.00 $582.00 | ||
Multitargeted receptor tyrosine kinase inhibitor, suppressing both VEGF and Ang-2-mediated angiogenesis. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
TGF-beta receptor inhibitor, indirectly affecting Ang-2 expression and angiogenesis. | ||||||
DCC-2036 | 1020172-07-9 | sc-364482 sc-364482A | 10 mg 50 mg | $480.00 $1455.00 | ||
Dual inhibitor of Tie2 and VEGFR2, reducing angiogenesis and blood vessel destabilization. | ||||||